J. Galli
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Toxicology top 5%
Papers in
-
- Renal Transplantation Outcomes and Treatments 2
-
- Head and Neck Cancer Studies 3
- Co-authors
- Frank K. FriedenbergGerard J. CrinerHuaqing ZhaoChandra DassKartik ShenoyA. James MamaryFrancis CordovaSameep Sehgal
- Journals
- Respiratory Medicine (2 papers)Lung (1 paper)Radiotherapy and Oncology (1 paper)Current Drug Abuse Reviews (1 paper)Respirology (1 paper)
- Partner nations
- United StatesItalyPhilippines
In The Last Decade
J. Galli
16 papers receiving 555 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 192
- Toxicology 36
- Pulmonary and Respiratory Medicine 268
- Endocrine and Autonomic Systems 44
- Transplantation 13
Countries citing papers authored by J. Galli
This map shows the geographic impact of J. Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Galli more than expected).
Fields of papers citing papers by J. Galli
This network shows the impact of papers produced by J. Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Galli. The network helps show where J. Galli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Galli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2021 | 14 | |
| 3 | 2021 | 6 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 36 | |
| 6 | 2019 | 1 | |
| 7 | 2017 | 13 | |
| 8 | 2017 | 206 | |
| 9 | 2014 | 45 | |
| 10 | 2013 | 1 | |
| 11 | 2011 | 214 | |
| 12 | 2000 | 1 | |
| 13 | [Prospects and therapeutic decisions in the light of biological findings in laryngeal cancer]. | 2000 | 3 |
| 14 | 1995 | 9 | |
| 15 | [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy]. | 1987 | 2 |
| 16 | [Primary liver carcinoma and seropositive amebiasis]. | 1986 | 1 |
About J. Galli
J. Galli is a scholar working on Transplantation, Otorhinolaryngology, Internal Medicine, Pulmonary and Respiratory Medicine and Radiological and Ultrasound Technology, having authored 16 papers that have together received 565 indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Head and Neck Cancer Studies (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Polyomavirus and related diseases (2 papers), Lung Cancer Treatments and Mutations (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Pharmacology (192 citations), Toxicology (36 citations), Pulmonary and Respiratory Medicine (268 citations), Endocrine and Autonomic Systems (44 citations) and Transplantation (13 citations). J. Galli has collaborated with scholars based in United States, Italy and Philippines. Frequent co-authors include Frank K. Friedenberg, Gerard J. Criner, Huaqing Zhao, Chandra Dass, Kartik Shenoy, A. James Mamary, Francis Cordova, Sameep Sehgal, James C. Brown and A.J. Mamary. Their work appears in journals such as Respiratory Medicine, Lung, Radiotherapy and Oncology, Current Drug Abuse Reviews and Respirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.